Christopher Pierce's Net Worth

$596 Thousand

Estimate Recalculated Jul 8, 2024 03:03PM EST

Who is Christopher Pierce?

Christopher Pierce does not have any significant net worth to report based on the numbers we have. This is based on reported shares in Prelude Therapeutics Inc.

SEC CIK

Christopher Pierce's CIK is 0001824631

Past Insider Trading and Trends

2021 was Christopher Pierce's most active year for acquiring shares with 5 total transactions. Christopher Pierce's most active month to acquire stocks was the month of March. 2021 was Christopher Pierce's most active year for disposing of shares, totalling 10 transactions. Christopher Pierce's most active month to dispose stocks was the month of March. 2021 saw Christopher Pierce paying a total of $226,620.47 for 106,323 shares, this is the most they've acquired in one year. In 2021 Christopher Pierce cashed out on 42,646 shares for a total of $882,445.87, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Prelude Therapeutics Inc (PRLD) Snapshot price: $2.92

EVP and Chief Business Oper

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
$27.27
-$490,042.70
3.75K
Scheduled
Sep 2
Form 4
—
0
—
—
0
Jul 20
Form 4
—
0
$21.09
-$126,537.23
3.75K
Scheduled
Apr 29
Form 4
—
0
$20.95
-$7,622.00
3.75K
Scheduled
Apr 8
Form 4
—
0
$20.99
-$31,623.47
3.75K
Scheduled
Apr 7
Form 4
∞
3.75K
$19.00
$71,250.00
3.75K
Sep 29
Form 3
—
0
—
—
0
No matching records found